The Latest Breaking News from Inflation

Finance Minister Shunichi Suzuki said on Tuesday that Japan would chair a Group of Seven (G7) financial leaders' meeting on Wednesday in Washington to discuss the global economy and financial markets, the strengthening of supply chains and the Ukraine crisis.

Consumers reduce spending on groceries, clothes and eating out as they seek to balance budgets

Most people today are coping with the rising cost of living individually: cost cutting, looking for a better paid job, taking on “side hustles”, and so on. But not so long ago, many workers globally and in Aotearoa New Zealand approached the same problem in far more collective ways.

There is no clear indication that the Fed would cease rate increases this year as inflation is well above its 2% goal. Persistent rate hikes and recent financial turmoil could potentially trigger a recession. At this time of uncertainty, investing in fundamentally sound REITs, Gaming and Leisure Properties (GLPI), Ladder…

Argentina's economy hit 100 per cent inflation in February — the highest it's been in 32 years. But the crisis has done nothing to dampen Argentines' enthusiasm for spending.

Despite inflation currently moderating, it is still significantly high and will continue to have an impact on consumer spending and eating habits this year. Therefore, fundamentally weak stocks Beyond Meat (BYND), Tattooed Chef (TTCF), and AppHarvest (APPH) could be best avoided. Read on.

With the Fed determined to curb inflation, high-interest rates are expected to stick around as it maintains its tough monetary policy stance. While this is expected to keep the stock market under pressure, investors should focus on their long-term portfolios and consider adding fundamentally strong growth stocks ASML Holding N.V.…

The Inflation Reduction Act imposes byzantine requirements to qualify for the credits. Some automakers are simply ignoring them and finding other ways to lower prices.

Since the high inflation is leading to rising healthcare spending, it could be wise to sell fundamentally weak medical stocks, Pacific Biosciences (PACB), DermTech (DMTK), and Genetic Technologies (GENE), before things get even uglier. Continue reading….